Key Highlights
- Jennifer Riter joins Kindeva Drug Delivery as Vice President of Analytical Services, leading the newly established global business unit.
- Riter brings over 27 years of experience from West Pharmaceutical, specializing in analytical testing for drug-device combination products.
- She will be presenting at industry conferences this spring, including the 2024 INTERPHEX Conference and the Pharma Ed Combination Products Summit.
Source: Business Wire
Notable Quotes
- “Kindeva’s expertise in all areas of drug delivery and manufacturing is unmatched in the industry. I am looking forward to expanding our capabilities and expertise in analytical services,” – Jennifer Riter, Vice President of Analytical Services at Kindeva
- “Jennifer’s experience…enhances Kindeva as a global drug-device combination CDMO and builds the future of integrated and stand-alone analytical support,” – David Stevens, Global Chief Commercial Officer at Kindeva
SoHC's Take
Jennifer Riter’s appointment marks a significant enhancement in Kindeva Drug Delivery’s global leadership position within the drug-device combination products sector. Her extensive experience and technical expertise in analytical testing and leadership roles position her uniquely to spearhead the newly announced analytical services unit. Riter’s forward-looking approach to expanding Kindeva’s capabilities and her commitment to working closely with customers on their analytical strategies promise to further solidify Kindeva’s status as a trailblazer in the industry. Her participation in upcoming industry conferences underscores her role as a thought leader and vital contributor to the future of drug-device combination products.
